RE-EVALUATION OF GENEXPERT AND EUTOS METHODS FOR THE MONITORING OF CHRONIC MYELOID LEUKEMIA (CML)

被引：0
|
作者：
Maria de las Nieves, Saez Perdomo [1 ]
Ortega Yanira, Florido [1 ]
Rodriguez Ramon, Reyes [1 ]
Santana Guillermo, Santana [1 ]
Henriquez Hugo, Luzardo [1 ]
Jose David, Gonzalez San Miguel [2 ]
Maria Teresa, Gomez Casares [1 ]
Maria Teresa, Molero Labarta [1 ]
机构：
[1] Hosp Univ Gran Canaria Dr Negrin, Las Palmas Gran Canaria, Las Palmas, Spain
[2] Complejo Hosp Univ Insular Materno Infantil, Las Palmas Gran Canaria, Las Palmas, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC 278
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [21] Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients
    Paul, T. Roshni
    Uppin, Shantveer G.
    Uppin, Megha S.
    Jacob, Rachel T.
    Rao, D. Raghunadha
    Rajappa, Senthil J.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2010, 26 (02): : 56 - 61
  • [22] FISH studies of peripheral blood cells for monitoring therapy in chronic myeloid leukemia (CML).
    Tchirkov, A
    Briançon, G
    Giollant, M
    Travade, P
    Lacroute, G
    Ait-Ouaret, FA
    Shah, FA
    Malet, P
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A326 - A326
  • [23] Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)
    Haznedaroglu, Ibrahim C.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01)
  • [24] Monitoring of minimal residual disease of patients with chronic myeloid leukemia (CML) treated with imatinib
    Herrera, P.
    Calbacho, M.
    Ramos, M. L.
    Heras, C.
    Ferro, M. T.
    Cabello, P.
    Villalon, L.
    Lopez, J.
    Odriozola, J.
    CHROMOSOME RESEARCH, 2005, 13 : 194 - 194
  • [25] Economic Modeling of the Potential Impact of Chronic Myeloid Leukemia (CML) Monitoring on Healthcare Costs
    Jabbour, Elias J.
    Siegartel, Lisa
    Lin, Jay
    Lingohr-Smith, Melissa
    Menges, Brandy
    Makenbaeva, Dinara
    BLOOD, 2017, 130
  • [26] Clinical significance of molecular monitoring in chronic myeloid leukemia (CML) in chronic phase (CP) with imatinib therapy
    Cortes, J
    Talpaz, M
    O'Brien, S
    Jones, D
    Luthra, R
    Garcia-Manero, G
    Giles, F
    Shan, J
    Verstovsek, S
    Rios, MB
    Kantarjian, H
    BLOOD, 2004, 104 (11) : 81A - 81A
  • [27] Monitoring response and treatment outcome in patients with chronic phase chronic myeloid leukemia (CML) treated with imatinib
    Teitelbaum, A.
    Spencer, D.
    Bollu, V. K.
    Chastek, B.
    Coombs, J.
    Kulakodlu, M.
    Morlock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Outcome and Prognosis of 1955 Patients with Chronic Myeloid Leukemia: First Results of the CML-Registry of the European Treatment and Outcome Study EUTOS.
    Hasford, Joerg
    Rosti, Gianantonio
    Lindoerfer, Doris
    Baccarani, Michele
    Guilhot, Joelle
    Montrucchio, Lara
    Rancati, Francesca
    Simonsson, Bengt
    Nicolini, Franck Emmanuel
    Ossenkoppele, Gert
    Hehlmann, Ruediger
    BLOOD, 2009, 114 (22) : 455 - 455
  • [29] EPIDEMIOLOGIC STUDIES OF CHRONIC MYELOID LEUKEMIA (CML) IN INDIA
    Levine, P. H.
    Hoffman, H.
    Mendizabal, A. M.
    Garcia-Gonzalez, V. Venkateshand P.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S254 - S254
  • [30] Outcome prediction of chronic myeloid leukemia (CML) in children
    Leung, Wing-Yan
    Cheuk, Daniel Ka-Leung
    Cheng, Frankie Wai-Tsoi
    Leung, Alex Wing-Kwan
    Chiu, Ka-Ho
    Ho, Karin Kar-Huen
    Li, Chak-Ho
    Chan, Godfrey Chi-Fung
    ANNALS OF HEMATOLOGY, 2022, 101 (08) : 1677 - 1688
12345